Figure 3.
Clinical correlation analysis. (a) A ceRNA network of esophageal cancer and ferroptosis. (b) Correlations among ADAM23, miR-372, and ARHGEF26-AS1. (c) The correlation between ADAM23 and ARHGEF26-AS1 (p < 0.0001). (d) The correlation between ADAM23 and hsa-miR-372 (p < 0.001). (e) Differential expression of ADAM23 in different clinical stages. (f) Association of ADAM23, miR-372, and ARHGEF26-AS1 with FPI. (g) Distribution of ADAM23 expression in human tissues.